Korean pharmaceutical firms, like Daewoong and Hanall, are embracing open innovation, partnering with global companies, including U.S. biotech firm Alloplex, to accelerate drug development and enhance their competitiveness in international markets.
To request interviews, high res images or other materials, media are asked to:
Email: media@alloplexbio.com
Attn: Lesley White, Alloplex Australia
For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013
